Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus

Mesenchymal stem cells (MSCs) are adult stem cells (ASCs) known for repairing damaged cells, exerting anti-inflammatory responses and producing immunoregulatory effects that can be significantly induced into insulin-producing cells (IPCs), providing an inexhaustible supply of functional β cells for...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Qiulan, Huang, Yanting, Liu, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178013/
https://www.ncbi.nlm.nih.gov/pubmed/34135959
http://dx.doi.org/10.1155/2021/9938658
_version_ 1783703498235314176
author Huang, Qiulan
Huang, Yanting
Liu, Jianping
author_facet Huang, Qiulan
Huang, Yanting
Liu, Jianping
author_sort Huang, Qiulan
collection PubMed
description Mesenchymal stem cells (MSCs) are adult stem cells (ASCs) known for repairing damaged cells, exerting anti-inflammatory responses and producing immunoregulatory effects that can be significantly induced into insulin-producing cells (IPCs), providing an inexhaustible supply of functional β cells for cell replacement therapy and disease modeling for diabetes. MSC therapy may be the most promising strategy for diabetes mellitus because of these significant merits. In this paper, we focused on MSC therapy for diabetes.
format Online
Article
Text
id pubmed-8178013
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-81780132021-06-15 Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus Huang, Qiulan Huang, Yanting Liu, Jianping Int J Endocrinol Review Article Mesenchymal stem cells (MSCs) are adult stem cells (ASCs) known for repairing damaged cells, exerting anti-inflammatory responses and producing immunoregulatory effects that can be significantly induced into insulin-producing cells (IPCs), providing an inexhaustible supply of functional β cells for cell replacement therapy and disease modeling for diabetes. MSC therapy may be the most promising strategy for diabetes mellitus because of these significant merits. In this paper, we focused on MSC therapy for diabetes. Hindawi 2021-05-28 /pmc/articles/PMC8178013/ /pubmed/34135959 http://dx.doi.org/10.1155/2021/9938658 Text en Copyright © 2021 Qiulan Huang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Huang, Qiulan
Huang, Yanting
Liu, Jianping
Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus
title Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus
title_full Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus
title_fullStr Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus
title_full_unstemmed Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus
title_short Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus
title_sort mesenchymal stem cells: an excellent candidate for the treatment of diabetes mellitus
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178013/
https://www.ncbi.nlm.nih.gov/pubmed/34135959
http://dx.doi.org/10.1155/2021/9938658
work_keys_str_mv AT huangqiulan mesenchymalstemcellsanexcellentcandidateforthetreatmentofdiabetesmellitus
AT huangyanting mesenchymalstemcellsanexcellentcandidateforthetreatmentofdiabetesmellitus
AT liujianping mesenchymalstemcellsanexcellentcandidateforthetreatmentofdiabetesmellitus

Ejemplares similares